Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel to consider lifting restrictions on Avandia based on new heart risk analysis
FDA panel to consider lifting restrictions on Avandia based on new heart risk analysis
FDA panel to consider lifting restrictions on Avandia based on new heart risk analysis
Submitted by
admin
on June 3, 2013 - 10:11am
Source:
Yahoo/AP
News Tags:
FDA
Avandia
GSK
diabetes
Headline:
FDA panel to consider lifting restrictions on Avandia based on new heart risk analysis
Do Not Allow Advertisers to Use My Personal information
